DaVita Inc. (DVA) Earnings Call Transcripts

28 earnings calls from February 2020 to October 29, 2026

New York Stock Exchange US Health Care Health Care Providers and Services

DaVita Inc.'s Latest Earnings Call - Q3 FY2026

In the third quarter of 2026, DaVita Inc. reported adjusted operating income of $561 million and adjusted earnings per share of $3.82, reflecting solid operational performance amid ongoing investments in technology and clinical innovations. Management raised guidance for Integrated Kidney Care (IKC) adjusted operating income to at least $65 million, an increase of $25 million over prior expectations, while narrowing full-year guidance for adjusted operating income to a range of $2.175 billion to $2.25 billion and adjusted earnings per share to $14.30 to $15.20. The company is poised for future growth driven by its new expanded HD dialyzer rollout and ongoing improvements in patient care metrics, although rising technology costs remain a concern.

Reported metrics

MetricValueContext
Adjusted Operating Income $561 million
Adjusted Earnings Per Share $3.82
Full Year Adjusted Operating Income Guidance $2.175 billion to $2.25 billion (inline) narrowing guidance ranges
IKC Adjusted Operating Income $65 million (beat) an increase of at least $25 million over the prior guidance
Free Cash Flow $276 million

Guidance from management

Management narrowed full-year guidance for adjusted operating income to $2.175 billion to $2.25 billion and for adjusted earnings per share to $14.30 to $15.20, reflecting increased IKC performance offset by higher U.S. dialysis costs.

What management said

Sure, I'll take that one, A.J., this is Javier. We agree with you. Our confidence and our capabilities in both the clinical and actuarial areas have now reached a point where we want to pursue more business. As we've stressed, what you want is healthy contracts, and you want your physician partners to be heavily involved. Our model of care is now scalable, and you need integrative tech, which we now have. We've got a...
— Javier Rodriguez, Q3 FY2026 earnings call
Thank you. I hope you can hear how excited we are in our voices, along with our physicians, our patients, and our caregivers; this ranks among the most excitement I've ever witnessed in the community. The brief response to your questions is that it's too early to say. This takes time, as the mortality studies show, and it takes time before any effect appears on the inflammatory side. When it comes to patients changin...
— Javier Rodriguez, Q3 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the impact of rising technology costs and the potential headwinds from the expiration of enhanced premium tax credits affecting patient volumes. There were also inquiries about the sustainability of treatment growth rates given recent mistreatment upticks.

Main topics on the call

Read the full DaVita Inc. transcript (Q3 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About DaVita Inc.

DaVita Inc. (DVA) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on New York Stock Exchange and is based in US. EarningsCalls.dev maintains a full-text archive of its earnings call transcripts — 28 calls on record spanning February 10, 2020 to October 29, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics. The latest calls are free to read; the full history is available through our REST API.

Earnings Call History

EarningsCalls.dev has 28 DaVita Inc. earnings call transcripts on record, spanning February 10, 2020 to October 29, 2026. Based on this history, DaVita Inc. reports quarterly. The most recent call on file is dated October 29, 2026. The full list is below — each row opens the transcript.

Ticker
DVA
Exchange
New York Stock Exchange
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
28
First call
February 10, 2020
Most recent
October 29, 2026
Reporting cadence
quarterly
Quarter Date
Q3 FY2026 Oct 29, 2026 Read transcript →
Q2 FY2026 Aug 4, 2026 Read transcript →
Q1 FY2026 May 5, 2026 Read transcript →
Q4 FY2025 Feb 2, 2026 Read transcript →
Q3 FY2025 Oct 29, 2025 Read transcript →
Q2 FY2025 Aug 5, 2025 Read transcript →
Q1 FY2025 May 12, 2025 Read transcript →
Q4 FY2024 Feb 13, 2025 Read transcript →
Q3 FY2024 Oct 29, 2024 Read transcript →
Q2 FY2024 Aug 6, 2024 Read transcript →
Q1 FY2024 May 2, 2024 Read transcript →
Q4 FY2023 Feb 13, 2024 Read transcript →
Q3 FY2023 Nov 7, 2023 Read transcript →
Q2 FY2023 Aug 3, 2023 Read transcript →
Q1 FY2023 May 8, 2023 Read transcript →
Q4 FY2022 Feb 22, 2023 Read transcript →
Q3 FY2022 Oct 28, 2022 Read transcript →
Q2 FY2022 Aug 1, 2022 Read transcript →
Q1 FY2022 May 5, 2022 Read transcript →
Q4 FY2021 Feb 10, 2022 Read transcript →
Q3 FY2021 Oct 28, 2021 Read transcript →
Q2 FY2021 Aug 3, 2021 Read transcript →
Q1 FY2021 Apr 29, 2021 Read transcript →
Q4 FY2020 Feb 11, 2021 Read transcript →
Q3 FY2020 Oct 29, 2020 Read transcript →
Q2 FY2020 Jul 30, 2020 Read transcript →
Q1 FY2020 May 5, 2020 Read transcript →
Q4 FY2019 Feb 10, 2020 Read transcript →